Prescribing for Unlabeled Conditions: Patient Benefit or Therapeutic Roulette?

Vital and health statistics. Hyattsville, MD: National Center for Health Statistics, 1979; DHEW publication no. (PHS) 79-1577, series 10; no 129.

Alpha reports. Scottsdale, AZ: PDS Inc., 1988: 1.

Goyan JE . Drug regulation: Quo vadis? JAMA 1988; 260: 3052–3.

Wardell WM . The history of drug discovery, development, and regulation. In: Grabowski HG Vernon JM . Regulation of pharmaceuticals, balancing the benefit and risk. Washington and London: American Enterprise Institute for Public Policy Research, 1983: 3–11.

Young FE Norris JA Levitt JA Nightingale SL . The FDA's new procedure for the use of investigational drugs in treatment. JAMA 1988; 259: 2267–70.

Finally, the patients benefit. Wall Street Journal 1988 Oct 20: A16, col 1.

Young FE Nightingale SL . Information on treatment IND's as they become available to the practitioner (editorial). JAMA 1988; 260: 247.

Young FE Nightingale SL . FDA's newly designated treatment IND's. JAMA 1988; 260: 224–5.

Waldholz M . Drug firms hope FDA broadens plan to speed approval of some medicines. Wall Street Journal 1988 Oct 21: B2, col 5.

Hayes A . The latest word from the FDA. An exclusive interview with the commissioner. Hosp Formul 1982; 17: 1063–75.

Nightingale SL . Use of drugs for unlabeled indications. Am Fam Physician 1986; 34: 269.

Use of approved drugs for unlabeled indications. FDA Drug Bull 1982; 12: 4.

Burnum JF . Medical practice a la mode. N Engl J Med 1987; 317: 1220–2.

Assessing the efficacy and safety of medical technologies. Washington, D.C.: Office of Technology Assessment. Publication no. 286/929. Sept. 1978.

Rucker TD . Pursuing rational drug therapy: A macro view a la the USA. J Soc Admin Pharm 1988; 5: 78–86.

Schade RR Donaldson RM . How physicians use cimetidine. N Engl J Med 1981; 304: 1281–4.

Cocco AE Cocco DV . A survey of cimetidine prescribing (letter). N Engl J Med 1981; 340: 1281.

MacDougall BRD Bailey RJ Williams R . H2-receptor antagonists and antacids in the prevention of acute gastrointestinal hemorrhage in fulminant hepatic failure: Two controlled trials. Lancet 1977; 1: 617–9.

Halloran LG Zfass AM Gayle WE Wheller CB Miller JD . Prevention of acute gastrointestinal complications after severe head injury: A controlled trial of cimetidine prophylaxis. Am J Surg 1980; 139: 44–8.

Iaafrate R Russell WL . Nonindicated use of cimetidine (letter). Am J Hosp Pharm 1980; 37: 1462, 1465.

Thomas CT Thomas E Reddy KR Martin E Stapleton J . Cimetidine usage for unlabeled conditions in ambulatory care service. South Med J 1984; 77: 1281–2.

FDA criticizes SK&F's Tagamet promotion. Script 1988; 1323: 16.

Erickson S Bergman H James J . The use of drugs for unlabeled indications. JAMA 1980; 243: 1543–6.

Solomon GD Steel JG Spaccavento LH . Verapamil prophylaxis of migraine. JAMA 1983; 250: 2500–4.

Ferlito S Fichera C Carria G . Effect of nifedipine on blood sugar, insulin and glucagon levels after oral glucose load. Panminerva Med 1981; 23: 75–80.

Greenwood RH . Hyperglycemic effect of nifedipine (letter). Br Med J 1982; 284: 50.

Charles S Ketegleger JM Buysschaer M . Hyperglycemic effect of nifedipine. Br Med J 1981; 283: 19–20.

Physicians Health Plan. Drug formulary. Minneapolis, MN: United Health Care Corporation, 1988: 3.

Mortenson LE . Audit indicates half of current chemotherapy uses lack FDA approval. J Cancer Program Manage 1988; 3: 21–5.

Levy M Lipshitz M Eliakin M . Hospital admissions due to adverse drug reactions. Am J Med Sci 1979; 277: 49–56.

FDA completes “Action Plan”; new IND guidelines approved. Am Pharm 1985; NS25: 596–7.

Castle M Wilfert CM Cate TR Osterhot S . Antibiotic use at Duke University Medical Center. JAMA 1977; 28: 19–22.

Johnson MM Mitch WE Heller AH Spaster R . The impact of an educational program on gentamicin use in a teaching hospital. Am J Med 1982; 73: 9–14.

Bater DC . Medical student education in clinical pharmacology and therapeutics. Ann Intern Med 1988; 108: 136–7.

Nieremberg DW . Report of survey of clinical pharmacology teaching in U.S. medical schools, and discussion of January 1986 Dartmouth workshop on teaching clinical pharmacology to medical students. Norristown, PA: American Society for Clinical Pharmacology and Therapeutics, 1986: 12–5.

Health and Public Policy Committee, American College of Physicians. Improving medical education in therapeutics. Ann Intern Med 1988; 108: 145–7.

National disease and therapeutics index (NDTI). Plymouth Meeting, PA: IMS America, 1988.